Abstract
Our aim was to determine whether the use of infliximab for rheumatoid arthritis (RA) patients is associated with an increased rate of postoperative complications. In this study we evaluated the serum concentration of infliximab to study the influence of autologous blood donation (AB donation) in patients who were administered infliximab and underwent total knee replacement (TKR). We examined five RA patients. Infliximab combined with methotrexate was administered at 3 mg/kg every 8 weeks for all patients. We carried out the TKR operation in the middle of the 8-week interval in which infliximab was administered. The AB donation consisted of 400 ml pooled AB drawn at one point 2 weeks following the final administration of infliximab. Serum infliximab levels were measured using an enzyme-linked immunosorbent assay. Mean serum infliximab levels were 5.46 ± 5.62 µg/ml 2 weeks after the final administration of infliximab, 2.02 ± 1.66 µg/ml just before the operation, and 1.48 ± 1.31 µg/ml 1 day post operation. Moreover, the mean serum level in an autologous blood bag sampled just before AB donation was 5.02 ± 4.79 µg/ml. This study indicated the serum level of infliximab in the stored blood remained at almost the same level as the collected autologous blood. However, even after autotransfusion those levels were decreased compared with levels measured just before the operation. Therefore, we conclude that there is little influence of AB donation on the risks of infliximab.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
R Anderson (1996) ArticleTitleThe orthopedic management of rheumatoid arthritis Arthritis Care Res 9 23–8
J Etchason L Petz E Keeler L Calhoun S Kleinman C Snider et al. (1995) ArticleTitleThe cost effectiveness of preoperative autologous blood donations N Engl J Med 332 719–24 Occurrence Handle7854380 Occurrence Handle10.1056/NEJM199503163321106 Occurrence Handle1:STN:280:ByqC2MjlvFY%3D
J Ledingham C Deighton InstitutionalAuthorNameBritish Society for Rheumatology Standards Guidelines and Audit Working Group (2005) ArticleTitleUpdate on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001) Rheumatology (Oxf) 44 157–63 Occurrence Handle10.1093/rheumatology/keh464 Occurrence Handle1:STN:280:DC%2BD2M%2FlsVSksA%3D%3D
RN Maini FC Breedveld JR Kalden JS Smolen D Davis JD Macfarlane et al. (1998) ArticleTitleTherapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1552–63 Occurrence Handle9751087 Occurrence Handle10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W Occurrence Handle1:CAS:528:DyaK1cXmsVChtbg%3D
PA Rosandich JT Kelley Suffix3rd DL Conn (2004) ArticleTitlePerioperative management of patients with rheumatoid arthritis in the era of biologic response modifiers Curr Opin Rheumatol 16 192–8 Occurrence Handle15103244 Occurrence Handle10.1097/00002281-200405000-00005 Occurrence Handle1:CAS:528:DC%2BD2cXksFGksb4%3D
DP Mooney M O'Reilly RL Gamelli (1990) ArticleTitleTumor necrosis factor and wound healing Ann Surg 211 124–9 Occurrence Handle2301991 Occurrence Handle10.1097/00000658-199002000-00002 Occurrence Handle1:STN:280:By%2BC2cnltVc%3D
L Marchal G D'Haens G Van Assche S Vermeire M Noman M Ferrante et al. (2004) ArticleTitleThe risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study Aliment Pharmacol Ther 19 749–54 Occurrence Handle15043515 Occurrence Handle10.1111/j.1365-2036.2004.01904.x Occurrence Handle1:CAS:528:DC%2BD2cXktVGnu7Y%3D
JF Colombel EV Loftus SuffixJr WJ Tremaine JH Pemberton BG Wolff T Young-Fadok et al. (2004) ArticleTitleEarly postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy Am J Gastroenterol 99 878–83 Occurrence Handle15128354 Occurrence Handle10.1111/j.1572-0241.2004.04148.x Occurrence Handle1:CAS:528:DC%2BD2cXlt1Cjur4%3D
JT Giles SJ Bartlett AC Gelber S Nanda K Fontaine V Ruffing et al. (2006) ArticleTitleTumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis Arthritis Rheum 15 IssueID55 333–7 Occurrence Handle10.1002/art.21841
SC Talwalkar DM Grennan J Gray P Johnson MJ Hayton (2005) ArticleTitleTumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery Ann Rheum Dis 64 650–1 Occurrence Handle15769927 Occurrence Handle10.1136/ard.2004.028365 Occurrence Handle1:STN:280:DC%2BD2M7jslGgsQ%3D%3D
D Wendling JC Balblanc A Brousse A Lohse G Lehuede P Garbuio et al. (2005) ArticleTitleSurgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures Ann Rheum Dis 64 1378–9 Occurrence Handle16100348 Occurrence Handle10.1136/ard.2005.037762 Occurrence Handle1:STN:280:DC%2BD2MvjtFKnsw%3D%3D
C Bibbo JW Goldberg (2004) ArticleTitleInfectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy Foot Ankle Int 25 331–5 Occurrence Handle15134615
K Nishimura N Wakimoto J Sasahara C Yanagisawa F Eda J Nishino et al. (2005) ArticleTitleNo change of infliximab levels in stored blood for preoperative autologous blood donation: a preliminary report Mod Rheumatol 15 302–4 Occurrence Handle17029083 Occurrence Handle10.1007/s10165-005-0404-z
SA Siegel DJ Shealy MT Nakada J Le DS Woulfe L Probert et al. (1995) ArticleTitleThe mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo Cytokine 7 15–25 Occurrence Handle7538333 Occurrence Handle10.1006/cyto.1995.1003 Occurrence Handle1:CAS:528:DyaK2MXjs1ehtL0%3D
BJ Scallon MA Moore H Trinh DM Knight J Ghrayeb (1995) ArticleTitleChimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions Cytokine 7 251–9 Occurrence Handle7640345 Occurrence Handle10.1006/cyto.1995.0029 Occurrence Handle1:CAS:528:DyaK2MXls1ait70%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mochizuki, T., Momohara, S., Ikari, K. et al. The serum concentration of infliximab in cases of autologous blood donation for patients with rheumatoid arthritis. Mod Rheumatol 17, 24–27 (2007). https://doi.org/10.1007/s10165-006-0539-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-006-0539-6